153 related articles for article (PubMed ID: 11943932)
1. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.
Carr ME; Martin EJ; Carr SL
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
Carr ME; Martin EJ; Kuhn JG; Seremetis SV
Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
[TBL] [Abstract][Full Text] [Related]
3. Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies.
Carr ME; Carr SL; Tildon T; Fisher LM; Martin EJ
J Thromb Haemost; 2003 Feb; 1(2):243-9. PubMed ID: 12871496
[TBL] [Abstract][Full Text] [Related]
4. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
5. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Carr ME
Haemophilia; 2007 Sep; 13(5):533-41. PubMed ID: 17880440
[TBL] [Abstract][Full Text] [Related]
7. Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Barrett JC; Ezban M
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):539-46. PubMed ID: 20581663
[TBL] [Abstract][Full Text] [Related]
8. Heparin ablates force development during platelet mediated clot retraction.
Carr ME; Carr SL; Greilich PE
Thromb Haemost; 1996 Apr; 75(4):674-8. PubMed ID: 8743198
[TBL] [Abstract][Full Text] [Related]
9. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
Jen CJ; McIntire LV
Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of calcium-induced reptilase clot retraction.
Kubisz P; Suranová J; Cronberg S
Scand J Haematol; 1976 Apr; 16(4):263-5. PubMed ID: 935809
[TBL] [Abstract][Full Text] [Related]
11. Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain.
Carr ME; Krishnaswami A; Martin EJ
Diabet Med; 2002 Oct; 19(10):862-6. PubMed ID: 12358876
[TBL] [Abstract][Full Text] [Related]
12. Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction.
Brophy DF; Martin EJ; Best AM; Gehr TW; Carr ME
J Thromb Haemost; 2004 Aug; 2(8):1299-304. PubMed ID: 15304034
[TBL] [Abstract][Full Text] [Related]
13. Blood coagulation in hemophilia A and hemophilia C.
Cawthern KM; van 't Veer C; Lock JB; DiLorenzo ME; Branda RF; Mann KG
Blood; 1998 Jun; 91(12):4581-92. PubMed ID: 9616154
[TBL] [Abstract][Full Text] [Related]
14. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
Niewiarowski S; Stewart GJ; Nath N; Sha AT; Lieberman GE
Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
[TBL] [Abstract][Full Text] [Related]
15. The structural properties and contractile force of a clot.
Jen CJ; McIntire LV
Cell Motil; 1982; 2(5):445-55. PubMed ID: 6891618
[TBL] [Abstract][Full Text] [Related]
16. Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT).
Carr ME; Martin EJ; Kuhn JG; Spiess BD
J Thromb Haemost; 2003 Sep; 1(9):1977-83. PubMed ID: 12941040
[TBL] [Abstract][Full Text] [Related]
17. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development.
Carr ME; Carr SL
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):79-86. PubMed ID: 7795157
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
De Clerck F; Borgers M; de Gaetano G; Vermylen J
Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
[TBL] [Abstract][Full Text] [Related]
19. Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus.
Krishnaswami A; Carr ME; Jesse RL; Kontos MC; Minisi AJ; Ornato JP; Vetrovec GW; Martin EJ
Thromb Haemost; 2002 Nov; 88(5):739-44. PubMed ID: 12428087
[TBL] [Abstract][Full Text] [Related]
20. Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h.
Brophy DF; Martin EJ; Christian Barrett J; Nolte ME; Kuhn JG; Gerk PM; Carr ME; Pelzer H; Agersø H; Ezban M; Hedner U
Haemophilia; 2011 Sep; 17(5):e949-57. PubMed ID: 21362113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
